Biolidics elaborates on scrapped deal with virus test kit distributor in the US

CATALIST-listed company Biolidics issued a statement on Friday to explain why its deal with Aytu Bioscience to distribute its novel conronavirus antibody test kits in the US has now been scrapped.

Biolidics said, in a statement responding to the Singapore Exchange's queries, that it has refunded all the deposits paid by Aytu for all undelivered orders, after the parties' mutual agreement to terminate the distribution agreement. Biolidics had announced earlier this week that the decision came about amid increased competition for such kits.

It said Aytu had a binding commitment to purchase an initial 500,000 kits by April 24, and had placed an order and made a deposit for 500,100 kits. By June 28, Biolidics had delivered 13,000 test kits to Aytu, which was to have been its sole distributor in the US. Biolidics has recorded revenue for these 13,000 kits.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US lawmaker seeks to ban Chinese firms from US capital marketsA top senator is preparing a bill to ban Chinese companies from U.S. capital markets if they engage in spying, human rights abuse or support ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

US lawmaker seeks to ban Chinese firms from US capital marketsWASHINGTON, DC: A top senator is preparing a bill to ban Chinese companies from US capital markets if they engage in spying, human rights abuse or ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »